Okta Director Sells $58K in Stock, Receives New 2,487 RSU Grant
Okta Director Jacques Frederic Kerrest reported multiple securities transactions on June 20, 2025.
Rhea-AI Filing Summary
Okta Director Jacques Frederic Kerrest reported multiple securities transactions on June 20, 2025. Key transactions include:
- Sold 581 shares of Class A Common Stock in two transactions at weighted average prices of $99.73 and $100.51
- Acquired 2,832 shares through RSU vesting
- Received a new grant of 2,487 RSUs on June 24, 2025, vesting in full by June 24, 2026
The filing also reveals substantial holdings including 1.25 million shares of Class B Common Stock held indirectly through trusts (convertible to Class A shares), and significant stock options with various strike prices ranging from $39.21 to $274.96. The transactions were executed under a Rule 10b5-1 trading plan established in September 2024. Notable is the executive's sabbatical period from November 2022 through October 2023, which affected certain RSU vesting schedules.
Positive
- Director Jacques Frederic Kerrest received a new grant of 2,487 RSUs, demonstrating continued alignment with shareholder interests
- Kerrest maintains substantial indirect ownership of 1,246,431 shares of Class B Common Stock through trusts, showing long-term commitment to the company
Negative
- Director Kerrest sold 581 shares at prices between $99.09-$101.025, though this was part of a pre-planned 10b5-1 trading plan
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
14 txns
Insider
Kerrest Jacques Frederic
Role
Director
Sold
581 shs ($58K)
Approx. gross sale proceeds
$58K
Approx. exercise cost
$0.00
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 2,487 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 2,832 | $0.00 | $0.00 |
| Sale | Class A Common Stock | 163 | $99.7341 | $16K |
| Sale | Class A Common Stock | 418 | $100.5106 | $42K |
| Exercise | Class A Common Stock | 2,832 | $0.00 | $0.00 |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Units — 5,015 contracts for 2,528 underlying shares (Direct);
Class A Common Stock — 2,832 shares (Direct);
Class B Common Stock — 1,246,431 contracts (Indirect, By Trust);
Employee Stock Option (Right to Buy) — 267,010 contracts (Direct)
Footnotes (9)
- F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 19, 2024.
- F2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.09 to $100.06 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.09 to $101.025 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Class A Common Stock.
- F5. The RSUs vested in full on June 20, 2025.
- F6. The RSUs vest in full on the earlier of June 24, 2026 or the date immediately prior to the Issuer's next regular annual stockholder meeting, subject to the Reporting Person's continued service to the Issuer through such vesting date.
- F7. 25% of the shares underlying the RSU vested on March 15, 2022, and the remaining shares underlying the RSU shall vest in 12 equal quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date, and subject to tolling from November 1, 2022 through October 31, 2023 per a Sabbatical Agreement between the Reporting Person and the Issuer.
- F8. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
- F9. The shares subject to the option are fully vested and exercisable by the Reporting Person.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What was the price range of OKTA stock sales by Kerrest in the June 20, 2025 transactions?
The shares were sold in multiple transactions with prices ranging from $99.09 to $101.025 per share. Specifically, the first batch sold for $99.09 to $100.06 per share, and the second batch sold for $100.09 to $101.025 per share.
How many Restricted Stock Units (RSUs) did OKTA director Kerrest receive in June 2025?
On June 24, 2025, Jacques Frederic Kerrest received 2,487 new Restricted Stock Units (RSUs) that will vest in full on the earlier of June 24, 2026 or the date immediately prior to OKTA's next regular annual stockholder meeting.
How many OKTA employee stock options does Kerrest currently hold?
Kerrest holds fully vested stock options for a total of 267,010 OKTA shares across different strike prices: 114,000 shares at $39.21, 71,547 shares at $82.16, 41,673 shares at $142.47, and two tranches totaling 39,790 shares at $274.96.
AI-generated analysis. How Rhea-AI works. Not financial advice.
